MND Diagnostics is a healthcare company focused on disease diagnosis. The medical device company has developed a diagnostic detection platform which aims to be rapid, low-priced and portable.

SPOC is a provider of a diagnostic medical device that identifies the specific myofacial (muscle) trigger points that SPOC says are often overlooked by conventional diagnosis which can cause neck and back pain. This device together with the patented clinical methodology developed by Dr. Norman Marcus, SPOC's chief medical officer and engaged in pain management, aim to provide a complete diagnostic package for accurate and precise identification of muscle pain.

NIR Diagnostics is developing a diagnostic device to quantitatively assess the progress of the wound healing process. Per the company, the device has the potential to be a more accurate, more rapid, and less expensive method of wound assessment compared to those currently on the market.

C2C is a medical device company developing a portfolio of medical devices.

Cord Blood Registry (CBR) is a newborn stem cell company. CBR is dedicated to advancing the clinical application of cord blood and cord tissue stem cells by partnering with institutions to establish FDA-regulated clinical trials for conditions that have no cure today.

AndroDx (Andro Diagnostics) is a medical device maker focused on making more accurate diagnostic tests for prostate cancer.